CEO Thomas P. Mathers sold $52K of Colucid Pharmaceuticals, Inc.

Sold$52,238

$34.78Price

1,502Shares

−1%Stake

What CLCD did after the filing

Prices for CLCD after this filing aren't in yet.

Traded Thu, Jan 5. Filed Thu, Jan 5, 11:37 AM ET, during the session. Not investment advice.